FindTrial
Sign In

Mucormycosis related cardiovascular changes study

To study incidence and evolution of cardiovascular changes in Mucor mycosis infection at a tertiary care centre in North India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041778
Enrollment
200
Registered
2022-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B49- Unspecified mycosis

Interventions

None listed

Sponsors

All India Institute of Medical Science Bathinda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age greater than 18 years nucor cases reporting to cardiology out patient department valid informed consent

Exclusion criteria

Exclusion criteria: not giving consent

Design outcomes

Primary

MeasureTime frame
Total cardiovascular events in the groupTimepoint: 4 weeks after presentation—

Secondary

MeasureTime frame
Characterization of inflammation on cardio-vascular outcomesTimepoint: 30 days post hospital admission;Incidence of acute myocardial events in Mucormycosis population â?¨at baseline and during hospital stayTimepoint: 30 days;Myocarditis or myocardial infarction or stenosis detected with ST segment elevation or depression associated with troponin elevation and echocardiographyTimepoint: 30 days post hospital admission;New onset cardiac arrhythmiaTimepoint: 30 days post hospital admission—

Countries

India

Contacts

Public ContactRohit Walia

All India Institute of Medical Science Bathinda

rwalia7731@yahoo.in8800492549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026